← 產業報告目錄
Peptide Drug Discovery Market Size, Share & Trends Analysis Distribution By Type Of Product (Synthetic Peptides, Biological And Recombinant Peptides And Macrocycles), Drug Discovery Steps (Target Identification And Validation, Hit Identification, Lead Generation And Lead Optimization), Therapeutic Area (Oncological Disorders, Metabolic Disorders, Cardiovascular Disorders, Infectious Disorders, Urological Disorders, Endocrine Disorders, CNS Disorders), By Company Size And Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-03頁數 180報告編號 INSIGHTACE-97d1b0e9bb
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
A CAGR of 11.3% is forecasted for the global Peptide Drug Discovery Market over the assessment period of 2024 through 2031.
The Peptide Drug Discovery sector involves a dynamic frontier in pharmaceutical research, offering a diverse array of therapeutic possibilities. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is fueled by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Peptide Drug Discovery Market Snapshot
Chapter 4. Global Peptide Drug Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Product Estimates & Trend Analysis
5.1. by Type of Product & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Product:
5.2.1. Synthetic Peptides
5.2.2. Biological Peptides
5.2.3. Recombinant Peptides
5.2.4. Macrocycles Peptides
Chapter 6. Market Segmentation 2: by Drug Discovery Steps Estimates & Trend Analysis
6.1. by Drug Discovery Steps & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Drug Discovery Steps:
6.2.1. Target Identification and Validation
6.2.2. Hit Identification
6.2.3. Lead Generation
6.2.4. Lead Optimization
Chapter 7. Market Segmentation 3: by Therapeutic Area Estimates & Trend Analysis
7.1. by Therapeutic Area & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Therapeutic Area:
7.2.1. Oncological disorders
7.2.2. Metabolic disorders
7.2.3. Cardiology Surgery
7.2.4. Neurology
7.2.5. Cardiovascular disorders
7.2.6. Infectious disorders
7.2.7. Urological disorders
7.2.8. Endocrine disorders
7.2.9. CNS disorders
7.2.10. Other diseases
Chapter 8. Market Segmentation 4: by Company Size Estimates & Trend Analysis
8.1. by Company Size & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Company Size:
8.2.1. Small
8.2.2. Mid-Sized
8.2.3. Large and very large
Chapter 9. Peptide Drug Discovery Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2023-2031
9.1.2. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2023-2031
9.1.3. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
9.1.4. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
9.1.5. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.2. Europe
9.2.1. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2023-2031
9.2.2. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2023-2031
9.2.3. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
9.2.4. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
9.2.5. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2023-2031
9.3.2. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2023-2031
9.3.3. Asia-Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
9.3.4. Asia-Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
9.3.5. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.4. Latin America
9.4.1. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2023-2031
9.4.2. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2023-2031
9.4.3. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
9.4.4. Latin Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
9.4.5. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2023-2031
9.5.2. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2023-2031
9.5.3. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
9.5.4. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2023-2031
9.5.5. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. GenScript
10.2.2. JPT Peptide Technologies
10.2.3. CPC Scientific
10.2.4. IRBM
10.2.5. Creative Peptides
10.2.6. Pepscan
10.2.7. Peptides and Macrocycle Drug Discovery Platform Providers
10.2.8. RA Pharmaceuticals
10.2.9. Pepticom
10.2.10. PeptiDream
10.2.11. Creative Biolabs
10.2.12. MeSCue-Janusys
10.2.13. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們